Table 1 Amplified in breast cancer 1 (AIB1) expression status and characteristics of the 167 lung adenocarcinoma patients
Characteristic | Total (cases) | AIB1 expression [cases (%)] | P | |
|---|---|---|---|---|
Normal expression | Overexpression | |||
Age (years) | 0.959 | |||
 ≤ 50a | 81 | 38 (46.9) | 43 (53.1) |  |
 > 50 | 86 | 40 (46.5) | 46 (53.5) |  |
Gender | 0.704 | |||
 Male | 118 | 54 (45.8) | 64 (54.2) |  |
 Female | 49 | 24 (49.0) | 25 (51.0) |  |
Tumor grade | 0.110 | |||
 G1 | 41 | 23 (56.1) | 18 (43.9) |  |
 G2 | 82 | 40 (48.8) | 42 (51.2) |  |
 G3 | 44 | 15 (34.1) | 29 (65.9) |  |
T status | 0.226 | |||
 T1–2 | 88 | 45 (51.1) | 43 (48.9) |  |
 T3–4 | 79 | 33 (41.8) | 46 (58.2) |  |
N status | 0.015 | |||
 N0 | 63 | 37 (58.7) | 26 (41.3) |  |
 N1–3 | 104 | 41 (39.4) | 63 (60.6) |  |
M status | 0.001 | |||
 M0 | 137 | 72 (52.6) | 65 (47.4) |  |
 M1 | 30 | 6 (20.0) | 24 (80.0) |  |
Stage | < 0.001 | |||
 I | 32 | 24 (75.0) | 8 (25.0) |  |
 II | 28 | 17 (60.7) | 11 (39.3) |  |
 III | 77 | 31 (40.3) | 46 (59.7) |  |
 IV | 30 | 6 (20.0) | 24 (80.0) |  |